/
Analyses & Displays for Hepatotoxicity

Analyses & Displays for Hepatotoxicity

Owned by Former user (Deleted)
Last updated: Apr 01, 2025 by Nicola Newton

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global

CURRENT STATUS Q1 2025

  • Stage 1 White paper has been completed and pending publication by the PHUSE Office.

Objectives & Deliverables

Timelines 
White PaperQ4 2023

Finalise Stage 2 of draft White Paper


Related content